Track topics on Twitter Track topics that are important to you
Tokyo-based Heartseed Inc. raised $26mm in its Series B financing to returning shareholder Astellas Venture Management and new backers SBI Investment, JMDC, Gene Techno Science, Nissay Capital, and SM...
Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company developing iPSC-derived cardiomyocytes for the treatment of heart failure (HF), today announced it has raised 2.8 Billion-yen (approx. ...
Heartseed Inc. was founded in 2015 to develop and commercialize cardiac regenerative medicine developed by Prof. Keiichi Fukuda and his group at the Department of Cardiology, Keio University, Tokyo. ...
We have published hundreds of Heartseed Inc. news stories on BioPortfolio along with dozens of Heartseed Inc. Clinical Trials and PubMed Articles about Heartseed Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Heartseed Inc. Companies in our database. You can also find out about relevant Heartseed Inc. Drugs and Medications on this site too.
Cardiology is a specialty of internal medicine. Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...